Cover Image
市場調查報告書

連續血糖監測系統的全球市場 - Guardian Real Time,FreeStyle Navigator,Dexcom Seven Plus,Dexcom G4 Platinum,MiniMed Paradigm Revel/Veo連續血糖監測系統及其他 - 產業分析、規模、市場佔有率、成長率、趨勢及預測

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 296696
出版日期 內容資訊 英文 68 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
連續血糖監測系統的全球市場 - Guardian Real Time,FreeStyle Navigator,Dexcom Seven Plus,Dexcom G4 Platinum,MiniMed Paradigm Revel/Veo連續血糖監測系統及其他 - 產業分析、規模、市場佔有率、成長率、趨勢及預測 Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年02月24日 內容資訊: 英文 68 Pages
簡介

本報告以Guardian Real Time、FreeStyle Navigator、Dexcom Seven Plus、Dexcom G4 Platinum、MiniMed Paradigm Revel/Veo等連續血糖監測系統(CGM)的產品市場為焦點,分就新產品銷售,銷售額,各地區勢力圖,使用率,技術開發,競爭環境等系數加以分析·檢驗,除了從全球觀點來看預測未來發展的轉變外,再彙整主要各企業的簡介,為您概述為以下內容。

第1章 序

  • 報告的內容說明
  • 市場區隔
  • 調查方法
    • 資訊來源
      • 二次調查(資訊搜尋等)
      • 一次調查(直接取材)
    • 前提

第2章 摘要整理

  • 市場概述:連續血糖監測系統的全球市場
  • 連續血糖監測系統的全球市場 - 設備·品牌別(單位:100萬美元)

第3章 市場概要

  • 概要
  • 市場推動要素
    • 糖尿病人口的全球性增加
    • 醫護檢查站(POCT)需求的擴大
  • 阻礙市場要素
    • 不利的醫療報酬制度
    • 校準問題
  • 市場機會
    • 開發以非侵入式技術為基礎的連續血糖監測系統
  • Portwe的波特的五力分析 - 連續血糖監測系統的全球市場
  • 市場向心力分析:連續血糖監測系統的全球市場 - 各地區

第4章 連續血糖監測系統(GCM)的全球市場 - 設備·品牌別(單位:100萬美元)

  • 概要
  • Guardian Real Time CGM System
  • FreeStyle Navigator
  • Dexcom Seven Plus CGM System
  • Dexcom G4 Platinum
  • MiniMed Paradigm Revel/Veo System
  • 其他

第5章 連續血糖監測系統的全球市場收益 - 各地區(單位:100萬美元)

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 競爭環境

  • 各主要企業市場佔有率分析:連續血糖監測系統的全球市場

第7章 建議

  • 亞太地區,中南美,中東·非洲的新興市場重視
  • 研究開發投資具有附加優勢的先進技術產品
  • 價格管理的投注力

第8章 企業簡介(企業概要,財務概要,產品系列,產業策略,最近的發展)

  • Abbott Laboratories
  • Bayer AG
  • Dexcom, Inc.
  • GlySens Incorporated
  • Insulet Corporation
  • Medtronic, Inc.
  • Nova Biomedical Corporation
  • Senseonics, Incorporated

圖表一覽

目錄

This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2013 to 2019.

Geographically, the continuous glucose monitoring market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global continuous glucose monitoring market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market shares. The report concludes with the profiles of major players in the global continuous glucose monitoring market such as Medtronic, Inc., Dexcom, Inc., Abbott Laboratories, Inc., Bayer AG, Nova Biomedical Corporation, Senseonics, Incorporated, GlySens, Incorporated and Insulet Corporation.

The global continuous glucose monitoring market is segmented as follows:

Continuous Glucose Monitoring Market, by Device/Brand

  • Guardian Real Time CGM System
  • FreeStyle Navigator
  • Dexcom Seven Plus CGM System
  • Dexcom G4 Platinum
  • MiniMed Paradigm Revel/Veo System
  • Others

Continuous Glucose Monitoring Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
    • 1.3.2 Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
  • 2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)

Chapter 3 Market Overview

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Rise in diabetic population globally
    • 3.2.2 Rise in demand for point of care testing (POCT)
  • 3.3 Market Restraints
    • 3.3.1 Unfavourable reimbursement policies
    • 3.3.2 Calibration issues
  • 3.4 Market Opportunities
    • 3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
  • 3.5 Porter's Five Forces Analysis for the Global Continuous Glucose Monitoring Market
    • 3.5.1 Bargaining power of suppliers
    • 3.5.2 Bargaining power of buyers
    • 3.5.3 Threat of substitutes
    • 3.5.4 Threat of new entrants
    • 3.5.5 Competitive Rivalry
  • 3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography

Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 - 2019 (USD Million)

  • 4.1 Overview
    • 4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 - 2019 (USD Million)
  • 4.2 Guardian Real Time CGM System
    • 4.2.1 Global Guardian Real Time CGM System Market, 2011 - 2019 (USD Million)
  • 4.3 FreeStyle Navigator
    • 4.3.1 Global FreeStyle Navigator Market, 2011 - 2019 (USD Million)
  • 4.4 Dexcom Seven Plus CGM System
    • 4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 - 2019 (USD Million)
  • 4.5 Dexcom G4 Platinum
    • 4.5.1 Global Dexcom G4 Platinum Market, 2011 - 2019 (USD Million)
  • 4.6 MiniMed Paradigm Revel/Veo System
    • 4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 - 2019 (USD Million)
  • 4.7 Others
    • 4.7.1 Global Other CGM Systems Market, 2011 - 2019 (USD Million)

Chapter 5 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)

  • 5.1 Overview
    • 5.1.1 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
    • 5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
  • 5.2 North America
    • 5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 Europe
    • 5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
    • 6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations

  • 7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
  • 7.2 Investing in research and development of technologically advanced products with added benefits
  • 7.3 Emphasis on price control

Chapter 8 Company Profiles

  • 8.1 Abbott Laboratories
    • 8.1.1 Company Overview
    • 8.1.2 Financial Overview
    • 8.1.3 Product Portfolio
    • 8.1.4 Business Strategies
    • 8.1.5 Recent Developments
  • 8.2 Bayer AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Overview
    • 8.2.3 Product Portfolio
    • 8.2.4 Business Strategies
    • 8.2.5 Recent Developments
  • 8.3 Dexcom, Inc.
    • 8.3.1 Company overview
    • 8.3.2 Financial overview
    • 8.3.3 Product Portfolio
    • 8.3.4 Business Strategies
    • 8.3.5 Recent Developments
  • 8.4 GlySens Incorporated
    • 8.4.1 Company overview
    • 8.4.2 Product Portfolio
    • 8.4.3 Business Strategies
  • 8.5 Insulet Corporation
    • 8.5.1 Company overview
    • 8.5.2 Financial overview
    • 8.5.3 Product portfolio
    • 8.5.4 Business Strategies
    • 8.5.5 Recent Developments
  • 8.6 Medtronic, Inc.
    • 8.6.1 Business Overview
    • 8.6.2 Financial Overview
    • 8.6.3 Product Portfolio
    • 8.6.4 Business Strategies
    • 8.6.5 Recent Development
  • 8.7 Nova Biomedical Corporation
    • 8.7.1 Company overview
    • 8.7.2 Product portfolio
    • 8.7.3 Business Strategies
    • 8.7.4 Recent Developments
  • 8.8 Senseonics, Incorporated
    • 8.8.1 Company overview
    • 8.8.2 Product portfolio
    • 8.8.3 Business Strategies
    • 8.8.4 Recent Developments

List of Figures

  • FIG. 1 Continuous Glucose Monitoring: Market Segmentation
  • FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
  • FIG. 3 Porter's Five Force Analysis: Global Continuous Glucose Monitoring Market
  • FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
  • FIG. 5 Global Guardian Real Time CGM System Market, 2011 - 2019 (USD Million)
  • FIG. 6 Global FreeStyle Navigator Market, 2011 - 2019 (USD Million)
  • FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 - 2019 (USD Million)
  • FIG. 8 Global Dexcom G4 Platinum Market, 2011 - 2019 (USD Million)
  • FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 - 2019 (USD Million)
  • FIG. 10 Global Other CGM Systems Market, 2011 - 2019 (USD Million)
  • FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
  • FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
  • FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 - 2012 (USD Million)
  • FIG. 18 Annual Revenue: Bayer AG., 2010 - 2012 (USD Million)
  • FIG. 19 Annual Revenue: Dexcom, Inc., 2010 - 2012 (USD Million)
  • FIG. 20 Annual Revenue: Insulet Corporation, 2010 - 2012 (USD Million)
  • FIG. 21 Annual Revenue: Medtronic, Inc., 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
  • TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
  • TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 - 2019 (USD Million)
  • TABLE 4 Global Continuous Glucose Monitoring Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top